Regorafenib (BAY 73‐4506): Antitumor and antimetastatic activities in preclinical models of colorectal cancer
Roberta Schmieder(Bayer (Germany)), Dieter Zopf(Bayer (Germany))
Cited by 137
Related Papers
Pharmacologic activity and pharmacokinetics of metabolites of regorafenib in preclinical models
|Cancer Medicine|2016|100